While the results were negative in the total study population, the hearing intervention slowed cognitive decline in older adults with mild to moderate hearing loss by 48% in a pre-specified segment of the study population consisting of the 238 people participating in an ongoing observational study of heart health.
CureVac Reports Progress in Intellectual Property Infringement Case Against BioNTech in Germany – Biotech Investments
Issuer: CureVac / Key word(s): Legal Matter 28.09.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Reports Progress